D-0007-2017 Class III Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0007-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Sep 13, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jul 2, 2018). Affected quantity: 31,762 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 12, 2016
Initiation Date
Sep 13, 2016
Termination Date
Jul 2, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,762 bottles

Product description

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceuticals Ind. Ltd. Halol- Baroda Highway, Halol-389 350, Gujarat, India. UPC 347335737868 NDC 47335-737-86

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

JKN5124A and JKN5229A, exp 10/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0007-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0007-2017. Report a data issue: hello@regdatalab.com.